Cytogen completes issuance of 5.2 billion won 7th series convertible bonds... potential dilution concern

Cytogen completed the issuance of 5.2 billion won in unregistered, unsecured private convertible bonds (7th series) on May 26, 2026.
The bonds are not listed on the exchange, with the payment date being May 26, 2026.
This issuance poses a potential dilution risk to existing shareholders if the bonds are converted into equity.
The initial board resolution was on May 18, 2026; the use of proceeds is not disclosed, presumably for working capital or debt refinancing.
Without conversion price details, stock price outlook remains uncertain; investors should monitor potential conversion events.